Cellular Therapeutics – Living Drugs: A Rising Star at the Horizon of Immunotherapy in Hematology and Oncology

per Humpe, Andreas, Köhl, Ulrike
Publicat a Transfus Med Hemother (2019)

Editorial: Modulation of Human Immune Parameters by Anticancer Therapies

per Sack, Ulrich, Tarnok, Attila, Preijers, Frank, Köhl, Ulrike, Na, Il-Kang
Publicat a Front Immunol (2020)

Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation

per Granzin, Markus, Wagner, Juliane, Köhl, Ulrike, Cerwenka, Adelheid, Huppert, Volker, Ullrich, Evelyn
Publicat a Front Immunol (2017)

Evaluating STAT5 Phosphorylation as a Mean to Assess T Cell Proliferation

per Bitar, Michael, Boldt, Andreas, Freitag, Marie-Theres, Gruhn, Bernd, Köhl, Ulrike, Sack, Ulrich
Publicat a Front Immunol (2019)

From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment

per Klöß, Stephan, Dehmel, Susann, Braun, Armin, Parnham, Michael J., Köhl, Ulrike, Schiffmann, Susanne
Publicat a Front Immunol (2020)

Galectin-9 Is a Suppressor of T and B Cells and Predicts the Immune Modulatory Potential of Mesenchymal Stromal Cell Preparations

per Ungerer, Christopher, Quade-Lyssy, Patricia, Radeke, Heinfried H., Henschler, Reinhard, Königs, Christoph, Köhl, Ulrike, Seifried, Erhard, Schüttrumpf, Jörg
Publicat 2014

Increased sMICA and TGFβ(1) levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells

per Klöß, Stephan, Chambron, Nicole, Gardlowski, Tanja, Arseniev, Lubomir, Koch, Joachim, Esser, Ruth, Glienke, Wolfgang, Seitz, Oliver, Köhl, Ulrike
Publicat a Oncoimmunology (2015)

Biohybrid cochlear implants in human neurosensory restoration

per Roemer, Ariane, Köhl, Ulrike, Majdani, Omid, Klöß, Stephan, Falk, Christine, Haumann, Sabine, Lenarz, Thomas, Kral, Andrej, Warnecke, Athanasia
Publicat a Stem Cell Res Ther (2016)

Clonal analysis of multipotent stromal cells derived from CD271(+) bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression

per Kuçi, Zyrafete, Seiberth, Julia, Latifi-Pupovci, Hatixhe, Wehner, Sibylle, Stein, Stefan, Grez, Manuel, Bönig, Halvard, Köhl, Ulrike, Klingebiel, Thomas, Bader, Peter, Kuçi, Selim
Publicat 2013

Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia

per Vyas, Maulik, Schneider, Ann-Charlott, Shatnyeva, Olga, Reiners, Katrin S., Tawadros, Samir, Kloess, Stephan, Köhl, Ulrike, Hallek, Michael, Hansen, Hinrich P., Pogge von Strandmann, Elke
Publicat a Oncoimmunology (2016)

Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry

per Shibru, Benjamin, Fey, Katharina, Fricke, Stephan, Blaudszun, André-René, Fürst, Friederike, Weise, Max, Seiffert, Sabine, Weyh, Maria Katharina, Köhl, Ulrike, Sack, Ulrich, Boldt, Andreas
Publicat a Front Immunol (2021)

Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients

per Reiners, Katrin S., Kessler, Jörg, Sauer, Maike, Rothe, Achim, Hansen, Hinrich P., Reusch, Uwe, Hucke, Christian, Köhl, Ulrike, Dürkop, Horst, Engert, Andreas, von Strandmann, Elke Pogge
Publicat 2013

Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids

per Klöss, Stephan, Chambron, Nicole, Gardlowski, Tanja, Weil, Sandra, Koch, Joachim, Esser, Ruth, Pogge von Strandmann, Elke, Morgan, Michael A., Arseniev, Lubomir, Seitz, Oliver, Köhl, Ulrike
Publicat a Front Immunol (2015)

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

per Kloess, Stephan, Ede Valverde da Silva, Alessa, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael, Pogge von Strandmann, Elke, Köhl, Ulrike
Publicat a Front Immunol (2017)

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

per Kloess, Stephan, Ede Valverde da Silva, Alessa, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael, Pogge von Strandmann, Elke, Köhl, Ulrike
Publicat a Front Immunol (2018)

First‐in‐human intracochlear application of human stromal cell‐derived extracellular vesicles

per Warnecke, Athanasia, Prenzler, Nils, Harre, Jennifer, Köhl, Ulrike, Gärtner, Lutz, Lenarz, Thomas, Laner‐Plamberger, Sandra, Wietzorrek, Georg, Staecker, Hinrich, Lassacher, Teresa, Hollerweger, Julia, Gimona, Mario, Rohde, Eva
Publicat a J Extracell Vesicles (2021)

Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms

per Priesner, Christoph, Esser, Ruth, Tischer, Sabine, Marburger, Michael, Aleksandrova, Krasimira, Maecker-Kolhoff, Britta, Heuft, Hans-Gert, Goudeva, Lilia, Blasczyk, Rainer, Arseniev, Lubomir, Köhl, Ulrike, Eiz-Vesper, Britta, Klöß, Stephan
Publicat a Front Immunol (2016)

Impaired Functionality of Antiviral T Cells in G-CSF Mobilized Stem Cell Donors: Implications for the Selection of CTL Donor

per Bunse, Carola E., Borchers, Sylvia, Varanasi, Pavankumar R., Tischer, Sabine, Figueiredo, Constança, Immenschuh, Stephan, Kalinke, Ulrich, Köhl, Ulrike, Goudeva, Lilia, Maecker-Kolhoff, Britta, Ganser, Arnold, Blasczyk, Rainer, Weissinger, Eva M., Eiz-Vesper, Britta
Publicat 2013

Functionality and Cell Senescence of CD4/ CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy® Platform

per Aleksandrova, Krasimira, Leise, Jana, Priesner, Christoph, Melk, Anette, Kubaink, Fanni, Abken, Hinrich, Hombach, Andreas, Aktas, Murat, Essl, Mike, Bürger, Iris, Kaiser, Andrew, Rauser, Georg, Jurk, Marion, Goudeva, Lilia, Glienke, Wolfgang, Arseniev, Lubomir, Esser, Ruth, Köhl, Ulrike
Publicat a Transfus Med Hemother (2019)

ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA

per Steinbach, Joachim P., Zhang, Congcong, Burger, Michael, Jennewein, Lukas, Schönfeld, Kurt, Genßler, Sabrina, Sahm, Christiane, Brendel, Christian, Naundorf, Sonja, Odendahl, Marcus, Köhl, Ulrike, Nowakowska, Paulina, Seifried, Erhard, Bönig, Halvard, Tonn, Torsten, Grez, Manuel, Mittelbronn, Michel, Wels, Winfried S.
Publicat 2014